The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 15, 2022

Filed:

Jul. 15, 2019
Applicant:

Neuracle Science Co., Ltd., Seoul, KR;

Inventors:

Jae Young Seong, Seoul, KR;

Jong-Ik Hwang, Seoul, KR;

Dong-Hoon Kim, Seoul, KR;

Gi Hoon Son, Seoul, KR;

Yoo-Na Lee, Seoul, KR;

Seongsik Yun, Daejeon, KR;

Arfaxad Reyes-Alcaraz, Seoul, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/08 (2006.01); A61K 38/00 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 25/22 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); A61P 25/06 (2006.01); A61K 9/00 (2006.01); A61K 9/19 (2006.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61K 9/00 (2013.01); A61K 9/0019 (2013.01); A61K 9/19 (2013.01); A61P 25/06 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 25/30 (2018.01); A61K 38/00 (2013.01);
Abstract

The present invention relates to spexin-based agonists specific for galanin receptor type 2 and use thereof. More specifically, the present invention provides peptide-based agonists with high specificity for galanin receptor type 2 and improved stability. The peptide-based agonists are involved in the regulation of in vivo physiological functions, such as food intake, anxiety, emotion, and addiction, for which galanin receptors type 2 is responsible, to effectively suppress appetite, help recover from anxiety disorder, and reduce pleasure addiction. Therefore, the peptide-based agonists can be used to prevent or treat galanin receptor type 2-mediated diseases.


Find Patent Forward Citations

Loading…